^
Association details:
Biomarker:MUS81 overexpression
Cancer:Gastric Cancer
Drug:SRA515 (BET inhibitor, BRD4 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer

Published date:
05/29/2019
Excerpt:
As expected, AZD5153 treatment significantly reduced the migration of gastric cancer cells overexpressing Mus81 in vitro and in vivo Collectively...Importantly, we demonstrate that the BRD4 inhibitor AZD5153 can potentially be used as an effective antimetastasis drug because of its effect on Mus81.
DOI:
10.1158/1535-7163.MCT-18-0833